These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35393273)

  • 21. Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites.
    Paulsen M; Lund C; Akram Z; Winther JR; Horn N; Møller LB
    Am J Hum Genet; 2006 Aug; 79(2):214-29. PubMed ID: 16826513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small amounts of functional ATP7A protein permit mild phenotype.
    Møller LB
    J Trace Elem Med Biol; 2015; 31():173-7. PubMed ID: 25172213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel mutation in the ATP7A gene in a Korean patient with Menkes disease.
    Kim YH; Lee R; Yoo HW; Yum MS; Bae SH; Chung SC; Park YM; Son JS
    J Korean Med Sci; 2011 Jul; 26(7):951-3. PubMed ID: 21738351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome.
    Tümer Z
    Hum Mutat; 2013 Mar; 34(3):417-29. PubMed ID: 23281160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A silent nucleotide substitution in the ATP7A gene in a child with Menkes disease.
    Møller LB; Rea G; Yasmeen S; Skjørringe T; Thorborg SS; Morrison PJ; Donnelly DE
    Mol Genet Metab; 2013 Dec; 110(4):490-2. PubMed ID: 24100245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbed copper transport in humans. Part 1: mutations of the ATP7A gene lead to Menkes disease and occipital horn syndrome.
    Seidel J; Møller LB; Mentzel HJ; Kauf E; Vogt S; Patzer S; Wollina U; Zintl F; Horn N
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL141-8. PubMed ID: 11936860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease.
    Dagenais SL; Adam AN; Innis JW; Glover TW
    Am J Hum Genet; 2001 Aug; 69(2):420-7. PubMed ID: 11431706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion.
    Kaler SG; Das S; Levinson B; Goldstein DS; Holmes CS; Patronas NJ; Packman S; Gahl WA
    Biochem Mol Med; 1996 Feb; 57(1):37-46. PubMed ID: 8812725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel deletion mutation of ATP7A gene in a Chinese family with Menkes disease.
    Zhang LP; Lü JL; Wang XH; Zou LP
    Chin Med J (Engl); 2008 Jan; 121(2):175-7. PubMed ID: 18272047
    [No Abstract]   [Full Text] [Related]  

  • 30. ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome.
    Gu YH; Kodama H; Murata Y; Mochizuki D; Yanagawa Y; Ushijima H; Shiba T; Lee CC
    Am J Med Genet; 2001 Mar; 99(3):217-22. PubMed ID: 11241493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel ATP7A gross deletion mutation in a Korean patient with Menkes disease.
    Park HD; Moon HK; Lee J; Lee M; Lee SY; Kim JW; Ki CS
    Ann Clin Lab Sci; 2009; 39(2):188-91. PubMed ID: 19429807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menkes disease in Korea: ATP7A mutation and epilepsy phenotype.
    Lee JS; Lim BC; Kim KJ; Hwang YS; Cheon JE; Kim IO; Seong MW; Park SS; Chae JH
    Brain Dev; 2015 Feb; 37(2):223-9. PubMed ID: 24882692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The copper-transporting capacity of ATP7A mutants associated with Menkes disease is ameliorated by COMMD1 as a result of improved protein expression.
    Vonk WI; de Bie P; Wichers CG; van den Berghe PV; van der Plaats R; Berger R; Wijmenga C; Klomp LW; van de Sluis B
    Cell Mol Life Sci; 2012 Jan; 69(1):149-63. PubMed ID: 21667063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomous requirements of the Menkes disease protein in the nervous system.
    Hodgkinson VL; Zhu S; Wang Y; Ladomersky E; Nickelson K; Weisman GA; Lee J; Gitlin JD; Petris MJ
    Am J Physiol Cell Physiol; 2015 Nov; 309(10):C660-8. PubMed ID: 26269458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual diagnosis: 8-day-old hypotonic newborn with sparse hair.
    Marques JS; Mateus M; Torres T; Santos H; Real MV; Santos F
    Pediatr Rev; 2014 Nov; 35(11):e53-6. PubMed ID: 25361912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A numerical investigation into possible mechanisms by that the A629P mutant of ATP7A causes Menkes Disease.
    Kouza M; Gowtham S; Seel M; Hansmann UH
    Phys Chem Chem Phys; 2010 Oct; 12(37):11390-7. PubMed ID: 20714486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel two-nucleotide deletion in the ATP7A gene associated with delayed infantile onset of Menkes disease.
    Wada T; Haddad MR; Yi L; Murakami T; Sasaki A; Shimbo H; Kodama H; Osaka H; Kaler SG
    Pediatr Neurol; 2014 Apr; 50(4):417-20. PubMed ID: 24630286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Copper transporting P-type ATPases and human disease.
    Cox DW; Moore SD
    J Bioenerg Biomembr; 2002 Oct; 34(5):333-8. PubMed ID: 12539960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menkes disease in affected females: the clinical disease spectrum.
    Smpokou P; Samanta M; Berry GT; Hecht L; Engle EC; Lichter-Konecki U
    Am J Med Genet A; 2015 Feb; 167A(2):417-20. PubMed ID: 25428120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable clinical expression of an identical mutation in the ATP7A gene for Menkes disease/occipital horn syndrome in three affected males in a single family.
    Borm B; Møller LB; Hausser I; Emeis M; Baerlocher K; Horn N; Rossi R
    J Pediatr; 2004 Jul; 145(1):119-21. PubMed ID: 15238919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.